Choosing the right therapy for a patient with asymptomatic carotid stenosis
Chrysi Bogiatzi1, M Reza Azarpazhooh2, J David Spence3
1Department of Neurology, McMaster University, Hamilton, Ontario, Canada.
Insights
Intensive medical therapy significantly lowers stroke risk for asymptomatic carotid stenosis (ACS) patients compared to surgical interventions like stenting (CAS) or endarterectomy (CEA). Intervention is reserved for a select few high-risk ACS individuals, with CEA often preferred over CAS.
Area of Science:
- Vascular Neurology
- Cardiovascular Medicine
- Interventional Neurology
Background:
- Asymptomatic carotid stenosis (ACS) presents a significant risk for stroke and cardiovascular events.
- Intensive medical therapy (IMT) has emerged as a safer alternative to surgical interventions for most ACS patients.
- The annual stroke/death risk with IMT is approximately 0.5%, contrasted with periprocedural risks of 2.5-4.1% for CAS and 1.4-1.8% for CEA.
Purpose of the Study:
- To emphasize the critical role of intensive medical therapy in managing asymptomatic carotid stenosis.
- To outline criteria for identifying ACS patients who may still benefit from carotid stenting (CAS) or carotid endarterectomy (CEA).
- To differentiate between optimal surgical candidates for CAS versus CEA.
Main Methods:
- Review of current treatment paradigms for asymptomatic carotid stenosis.
- Analysis of risk stratification for cardiovascular events in ACS patients.
- Evaluation of clinical and imaging markers to identify high-risk individuals.
Main Results:
- Intensive medical therapy is associated with a substantially lower annual risk of stroke or death (~0.5%) compared to CAS (2.5-4.1%) or CEA (1.4-1.8%).
- The periprocedural risk associated with CAS is notably higher, particularly in older patient populations.
- Specific clinical and imaging features can identify a subset of ACS patients who might benefit from intervention.
Conclusions:
- All patients with asymptomatic carotid stenosis should receive comprehensive intensive medical therapy, including lifestyle changes, lipid management, B vitamins, and antithrombotics.
- High-risk ACS patients suitable for intervention can be identified through markers such as TCD emboli detection, plaque ulceration, intraplaque hemorrhage, reduced cerebrovascular reserve, and silent brain infarcts.
- Carotid endarterectomy is generally the preferred intervention over carotid stenting for most ACS patients requiring surgical treatment.
Abstract:
Introduction: Most patients with asymptomatic carotid stenosis (ACS) now have a lower risk with intensive medical therapy than with stenting (CAS) or endarterectomy (CEA); the annual risk of stroke or death with intensive medical therapy is ~ 0.5%, vs. a periprocedural risk with CAS of ~ 2.5-4.1% with CAS, and ~ 1.4-1.8% with CEA. The excess risk of CAS is greater in older patients.Areas covered: Discussed are the need for intensive medical therapy, the nature of intensive medical therapy, approaches to identifying the few patients with ACS who could benefit from CEA or CAS, and which patients would be better suited to CEA vs. CAS.Expert opinion: All patients with ACS are at high risk of cardiovascular events, soshould receive intensive medical therapy including lifestyle modification, intensive lipid-lowering, B vitamins to lower homocysteine (using methylcobalamin rather than cyanocobalamin), and appropriate antithrombotic therapy. High-risk patients who could benefit from intervention can be identified by clinical and imaging features including transcranial Doppler embolus detection, ulceration, intraplaque hemorrhage, reduced cerebrovascular reserve, plaque echolucency, silent infarction on brain imaging, and progression of stenosis. Most patients whose risk of stroke warrants intervention would be better treated with CEA than with CAS.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:23Atherosclerosis IV: Nursing Management
01:26Atherosclerosis III: Management
01:26Aneurysm III: Interprofessional Care
01:26Angina IV: Management
01:27Peripheral Artery Disease III: Interprofessional Care